Aadi Bioscience, Inc. Banner Image

Aadi Bioscience, Inc.

  • Ticker AADI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aadi Bioscience, Inc. Logo Image
  • 51-200 Employees
  • Based in Los Angeles, California
Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically defined cancers to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Aadi received FDA approval in November 2021, and in February 2022 commenced commercialization of FYARRO® for the treatment of adult patients with locally advanced unresectable or metastaticMore malignant perivascular epithelioid cell tumor (PEComa).
4.8 / 5.0 (284)

Aadi Bioscience, Inc. reports have an aggregate usefulness score of 4.8 based on 284 reviews.

Aadi Bioscience, Inc.

Most Recent Annual Report

Aadi Bioscience, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Aadi Bioscience, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!